UK markets closed

Cellectis S.A. (CLLS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.5500+0.0800 (+3.24%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
16,496
19,171
30,346
51,057
Cost of revenue
1,261
1,772
1,844
1,951
Gross profit
15,235
17,399
28,502
49,106
Operating expenses
Research development
83,553
97,501
117,840
77,048
Selling general and administrative
9,514
10,782
12,450
12,766
Total operating expenses
88,732
107,065
131,985
91,418
Operating income or loss
-73,497
-89,666
-103,483
-42,312
Interest expense
4,695
3,787
4,171
2,407
Total other income/expenses net
-11,347
6,060
9,741
-10,590
Income before tax
-78,575
-98,600
-96,753
-53,582
Income tax expense
452
87
0
0
Income from continuing operations
-79,026
-98,688
-96,749
-53,581
Net income
-85,010
-106,139
-114,197
-81,074
Net income available to common shareholders
-85,010
-106,139
-114,197
-81,074
Basic EPS
-1.66
-2.33
-2.55
-1.91
Diluted EPS
-1.66
-2.33
-2.55
-1.91
Basic average shares
52,088
45,547
44,820
42,503
Diluted average shares
52,088
45,547
44,820
42,503